< Go Back

STEM-Pharma® to Attend the 5th Innovation Days and Emerging Market Access Conference in Paris
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease
Pivotal Therapeutics Grants Incentive Stock Options
Asthma Market to Reach 161.02 million Cases in 10MM by 2023
Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017
Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox
Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density
CaPtivate Pharmaceuticals Enters License Agreement With Immunotope
myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO
Ampio Pharmaceuticals Announces Webcast for Annual Shareholder Meeting
More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar
First European Patients Enrolled in QT Vascular's ENDURE Trial
PDL BioPharma Completes Regular Quarterly Dividend Payment
Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014
Closed Drug Transfer Systems to 2020
Lupus Research Institute Launches NYC's First Lupus Trials Fair
Sysmex America, Inc. Renews LABSCO Distributorship
Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents
MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot
Mariel Therapeutics Appoints World Leading Experts to Inaugural Scientific Advisory Board
Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device
Bayer HealthCare Announces the Launch of Aleve® PM: The First and Only OTC PM Pain Reliever with a Sleep Aid Plus the 12-Hour Pain Relieving Strength of Aleve
Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap
Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange
Oramed to Present at Family Office & Wealth Management Conference
Congress, MAGIC Call for Early Detection and Awareness of Children's Growth Patterns
Retrospective Study Shows SURGICEL® Family of Topical Absorbable Hemostats Decreases Hospital Resource Use and Lowers Associated Costs
Shire Announces FDA Acceptance for Filing with Priority Review of Supplemental New Drug Application (sNDA) for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) for Adults with Binge Eating Disorder
Purdue Pharma L.P. Names Susie Robinson Vice President of Human Resources
BioHealth Innovation Signs Agreement with Roche to Source Technologies for Research, Development and Commercialization
FDA accepts Tuzistra™ XR (CCP-01) NDA for full review
OTC Markets Group Welcomes Antibe Therapeutics to OTCQX®
Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries
Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019
HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014
Pharmaceutical Sector Turning to Health Outcomes Liaisons to Help Industry Navigate Payer-Focused Marketplace
Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Impax Laboratories, Inc. and Certain Officers - IPXL
U.S. Genomics Market and Global Genomics Industry 2018 Forecasts in New Research Reports
Global Diclofenac Industry Report 2014
Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)
FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014
Merck KGaA Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer

< Prev Next >
PR Newswire - United Business Media